Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

Lantos PM, Charini WA, Medoff G, Moro MH, Mushatt DM, Parsonnet J, Sanders JW, Baker CJ.

Clin Infect Dis. 2010 Jul 1;51(1):1-5. doi: 10.1086/654809.

PMID:
20504239
2.

Bartonella species-induced prosthetic valve endocarditis associated with rapid progression of valvular stenosis.

Kreisel D, Pasque MK, Damiano RJ Jr, Medoff G, Kates A, Kreisel FH, Lawton JS.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):567-8. No abstract available.

3.

Soliciting patient complaints to improve performance.

Garbutt J, Bose D, McCawley BA, Burroughs T, Medoff G.

Jt Comm J Qual Saf. 2003 Mar;29(3):103-12.

PMID:
12635426
4.

A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B.

Fichtenbaum CJ, German M, Dunagan WC, Fraser VJ, Medoff G, Diego J, Powderly WG.

Clin Infect Dis. 1999 Dec;29(6):1551-6.

PMID:
10585811
5.

New challenges to the therapy of systemic fungal infections.

Medoff G.

Trans Am Clin Climatol Assoc. 1996;107:146-57; discussion 157-8. Review.

6.

Screening of physicians for tuberculosis.

Fraser VJ, Kilo CM, Bailey TC, Medoff G, Dunagan WC.

Infect Control Hosp Epidemiol. 1994 Feb;15(2):95-100.

PMID:
8201241
7.

Results of a rubella screening program for hospital employees: a five-year review (1986-1990).

Fraser V, Spitznagel E, Medoff G, Dunagan WC.

Am J Epidemiol. 1993 Nov 1;138(9):756-64.

PMID:
8237990
8.

Evaluation of rooms with negative pressure ventilation used for respiratory isolation in seven midwestern hospitals.

Fraser VJ, Johnson K, Primack J, Jones M, Medoff G, Dunagan WC.

Infect Control Hosp Epidemiol. 1993 Nov;14(11):623-8.

PMID:
8132981
9.

Formulary control of antimicrobial usage. What price freedom?

Dunagan WC, Medoff G.

Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):265-74.

PMID:
8477583
10.

Evaluation of new antifungal drugs for the treatment of systemic fungal infections. Infectious Diseases Society of America and the Food and Drug Administration.

Medoff G, Dismukes WE, Pappagianis D, Diamond R, Gallis HA, Drutz D.

Clin Infect Dis. 1992 Nov;15 Suppl 1:S274-81.

PMID:
1477243
11.

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.

Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC.

Clin Infect Dis. 1992 Sep;15(3):414-21. Review.

PMID:
1520786
12.

Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene.

Keath EJ, Kobayashi GS, Medoff G.

J Clin Microbiol. 1992 Aug;30(8):2104-7.

13.

Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine.

Fraser VJ, Jones M, Murray PR, Medoff G, Zhang Y, Wallace RJ Jr.

Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):853-5.

PMID:
1554214
14.

Antimicrobial use in otolaryngeal infections: general considerations.

Medoff G.

Ann Otol Rhinol Laryngol Suppl. 1992 Jan;155:5-8.

PMID:
1728901
15.

Characterization of CARE-1: Candida albicans repetitive element-1.

Lasker BA, Page LS, Lott TJ, Kobayashi GS, Medoff G.

Gene. 1991 Jun 15;102(1):45-50.

PMID:
1864508
16.

Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides.

Dunagan WC, Woodward RS, Medoff G, Gray JL, Casabar E, Lawrenz C, Spitznagel E, Smith MD.

Rev Infect Dis. 1991 May-Jun;13(3):405-12.

PMID:
1866543
17.

Systemic fungal infections: an overview.

Medoff G, Kobayashi GS.

Hosp Pract (Off Ed). 1991 Feb 15;26(2):41-52. Review.

PMID:
1899254
18.

Structure-activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose.

Gruda I, Milette D, Brother M, Kobayashi GS, Medoff G, Brajtburg J.

Antimicrob Agents Chemother. 1991 Jan;35(1):24-8.

19.

Inhibition of amphotericin B (Fungizone) toxicity to cells by egg lecithin-glycocholic acid mixed micelles.

Brajtburg J, Elberg S, Kobayashi GS, Medoff G.

Antimicrob Agents Chemother. 1990 Dec;34(12):2415-6.

20.

Temperature-sensitive variants of Histoplasma capsulatum isolated from patients with acquired immunodeficiency syndrome.

Spitzer ED, Keath EJ, Travis SJ, Painter AA, Kobayashi GS, Medoff G.

J Infect Dis. 1990 Jul;162(1):258-61.

PMID:
1972383
22.

In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.

Kobayashi GS, Travis SJ, Rinaldi MG, Medoff G.

Antimicrob Agents Chemother. 1990 Apr;34(4):524-8.

23.

Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice.

Kobayashi GS, Travis SJ, Medoff G.

Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S291-3.

PMID:
2330487
24.

Amphotericin B: delivery systems.

Brajtburg J, Powderly WG, Kobayashi GS, Medoff G.

Antimicrob Agents Chemother. 1990 Mar;34(3):381-4. Review. No abstract available.

25.

Amphotericin B: current understanding of mechanisms of action.

Brajtburg J, Powderly WG, Kobayashi GS, Medoff G.

Antimicrob Agents Chemother. 1990 Feb;34(2):183-8. Review. No abstract available.

26.
27.

DNA probe for the identification of Histoplasma capsulatum.

Keath EJ, Spitzer ED, Painter AA, Travis SJ, Kobayashi GS, Medoff G.

J Clin Microbiol. 1989 Oct;27(10):2369-72.

28.

Antimicrobial misuse in patients with positive blood cultures.

Dunagan WC, Woodward RS, Medoff G, Gray JL 3rd, Casabar E, Smith MD, Lawrenz CA, Spitznagel E.

Am J Med. 1989 Sep;87(3):253-9.

PMID:
2773963
29.

Effects of ascorbic acid on the antifungal action of amphotericin B.

Brajtburg J, Elberg S, Kobayashi GS, Medoff G.

J Antimicrob Chemother. 1989 Sep;24(3):333-7.

PMID:
2681119
30.

Comparison of the separation of Candida albicans chromosome-sized DNA by pulsed-field gel electrophoresis techniques.

Lasker BA, Carle GF, Kobayashi GS, Medoff G.

Nucleic Acids Res. 1989 May 25;17(10):3783-93.

31.

Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum.

Spitzer ED, Lasker BA, Travis SJ, Kobayashi GS, Medoff G.

Infect Immun. 1989 May;57(5):1409-12.

32.
33.

Electrophoretic analysis of Histoplasma capsulatum chromosomal DNA.

Steele PE, Carle GF, Kobayashi GS, Medoff G.

Mol Cell Biol. 1989 Mar;9(3):983-7.

34.

Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids.

Jullien S, Contrepois A, Sligh JE, Domart Y, Yeni P, Brajtburg J, Medoff G, Bolard J.

Antimicrob Agents Chemother. 1989 Mar;33(3):345-9.

35.

Effects of the detergent sucrose monolaurate on binding of amphotericin B to sterols and its toxicity for cells.

Gruda I, Gauthier E, Elberg S, Brajtburg J, Medoff G.

Biochem Biophys Res Commun. 1988 Aug 15;154(3):954-8. Erratum in: Biochem Biophys Res Commun 1988 Oct 31;156(2):1061.

PMID:
3044370
36.

Aspergillosis in the immunocompromised host.

Medoff G, Kobayashi GS.

N Engl J Med. 1988 May 5;318(18):1207. No abstract available.

PMID:
3362172
37.

Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B.

Sokol-Anderson M, Sligh JE Jr, Elberg S, Brajtburg J, Kobayashi GS, Medoff G.

Antimicrob Agents Chemother. 1988 May;32(5):702-5.

38.

Amphotericin B-resistant yeast infection in severely immunocompromised patients.

Powderly WG, Kobayashi GS, Herzig GP, Medoff G.

Am J Med. 1988 May;84(5):826-32.

PMID:
3284339
39.

Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.

Brajtburg J, Elberg S, Kobayashi GS, Medoff G.

Antimicrob Agents Chemother. 1988 Mar;32(3):327-30.

40.

Heat-shock proteins induced during the mycelial-to-yeast transitions of strains of Histoplasma capsulatum.

Shearer G Jr, Birge CH, Yuckenberg PD, Kobayashi GS, Medoff G.

J Gen Microbiol. 1987 Dec;133(12):3375-82.

PMID:
3503922
41.

Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice.

Kobayashi GS, Travis SJ, Medoff G.

Antimicrob Agents Chemother. 1987 Dec;31(12):2005-6.

42.

Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.

Woodward RS, Medoff G, Smith MD, Gray JL 3rd.

Am J Med. 1987 Nov;83(5):817-23.

PMID:
3674089
43.
44.
45.

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, Shadomy S, Stamm AM, Diasio RB, Kaufman L, Soong S, Blackwelder WC; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

N Engl J Med. 1987 Aug 6;317(6):334-41.

PMID:
3299095
46.

Morphogenesis and pathogenicity of Histoplasma capsulatum.

Medoff G, Kobayashi GS, Painter A, Travis S.

Infect Immun. 1987 Jun;55(6):1355-8.

47.
48.

Correlation between pathogenicity and temperature sensitivity in different strains of Histoplasma capsulatum.

Medoff G, Maresca B, Lambowitz AM, Kobayashi G, Painter A, Sacco M, Carratu L.

J Clin Invest. 1986 Dec;78(6):1638-47.

50.

Supplemental Content

Loading ...
Support Center